Old Web
English
Sign In
Acemap
>
Paper
>
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
2021
Joseph Mikhael
Karim Belhadj-Merzoug
Cyrille Hulin
Laure Vincent
Philippe Moreau
Cristina Gasparetto
Luděk Pour
Ivan Spicka
Ravi Vij
Jeffrey A. Zonder
Djordje Atanackovic
Nashat Y. Gabrail
Thomas G. Martin
Aurore Perrot
Samira Bensfia
Qilong Weng
Claire Brillac
Dorothée Semiond
Sandrine Macé
Kathryn P Corzo
Xavier Leleu
Keywords:
Multiple myeloma
Phases of clinical research
Oncology
Internal medicine
Daratumumab
in patient
Text mining
MEDLINE
Refractory
Isatuximab
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
11
References
7
Citations
NaN
KQI
[]